{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:46:42Z","timestamp":1785757602924,"version":"3.56.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.msard.2026.107026","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T17:10:44Z","timestamp":1769101844000},"page":"107026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["First demyelinating attack in children: A twelve year single center cohort"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8901-9124","authenticated-orcid":false,"given":"Alessandro","family":"Santagostino Barbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thea","family":"Giacomini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Casabona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"De Grandis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucrezia","family":"Sartore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Calevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica Maria","family":"Bozzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela Maria","family":"Mobilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Inglese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Cellerino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Stella","family":"Vari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Cordani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampaola","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Amadori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Canale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Striano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Resaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Buratti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Brisca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luana","family":"Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Franciotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Gastaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lino","family":"Nobili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Margherita","family":"Mancardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107026_bib0001","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000001008","article-title":"Use of disease-modifying therapies in pediatric relapsing-remitting multiple sclerosis in the United Kingdom","volume":"8","author":"Abdel-Mannan","year":"2021","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107026_bib0002","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S1474-4422(19)30488-0","article-title":"Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study","volume":"19","author":"Armangue","year":"2020","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0003","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","article-title":"Diagnosis of myelin oligodendrocyte glycoprotein antibody-associated disease: international MOGAD Panel proposed criteria","volume":"22","author":"Banwell","year":"2023","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0004","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.msard.2019.06.002","article-title":"Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008\u20122018: a nationwide, population-based cohort study","volume":"33","author":"Boesen","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107026_bib0005","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1136\/jnnp-2017-316286","article-title":"Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders","volume":"89","author":"Bonnan","year":"2018","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107026_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105950","article-title":"Clinical characteristics of pediatric and adult myelin oligodendrocyte antibody-associated disease (MOGAD): a single-center study in the Northeast","volume":"92","author":"Brown","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107026_bib0007","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000200456","article-title":"Real-life evaluation of the MOGAD diagnostic criteria: application challenges and discrepancies","volume":"12","author":"Carta","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107026_bib0008","doi-asserted-by":"crossref","DOI":"10.1007\/s11916-024-01322-7","article-title":"Pain and headache in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"29","author":"Diaz","year":"2025","journal-title":"Curr. Pain. Headache Rep."},{"key":"10.1016\/j.msard.2026.107026_bib0009","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/dmcn.14912","article-title":"Long-term trajectory of acquired demyelinating syndrome and multiple sclerosis in children","volume":"63","author":"Eusebi","year":"2021","journal-title":"Dev. Med. Child Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0010","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1474-4422(20)30432-4","article-title":"Paediatric multiple sclerosis and antibody-associated demyelination: clinical, imaging, and biological considerations for diagnosis and care","volume":"20","author":"Fadda","year":"2021","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102011","article-title":"Seizures and myelin oligodendrocyte glycoprotein (MOG) antibodies: two paradigmatic cases and a review of the literature","volume":"41","author":"Foiadelli","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107026_bib0012","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000209682","article-title":"Investigating the 2023 MOGAD criteria in children and adults with MOG-antibody positivity within and outside attacks","volume":"103","author":"Fonseca","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107026_bib0013","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200400","article-title":"Clinical features of children with MOG-IgG who fulfill criteria of multiple sclerosis and overlapping disorders","volume":"12","author":"Fonseca","year":"2025","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107026_bib0014","article-title":"Pediatric acquired demyelinating disorders","author":"Goldman","year":"2022","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2023.101050","article-title":"Monophasic acquired demyelinating syndromes of the Central nervous system in children","volume":"46","author":"Hardy","year":"2023","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2023.1260358","article-title":"Epidemiology of myelin oligodendrocyte glycoprotein antibody-associated disease: a review of prevalence and incidence worldwide","volume":"14","author":"Hor","year":"2023","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0017","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1007\/s13760-021-01703-4","article-title":"Evaluation of inflammatory acquired demyelinating syndromes in children: a single-center experience","volume":"122","author":"Kilic","year":"2022","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.msard.2026.107026_bib0018","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1177\/1352458513484547","article-title":"International Pediatric Multiple Sclerosis Study Group criteria for pediatric multiple sclerosis and immune-mediated central nervous system demyelinating disorders: revisions to the 2007 definitions","volume":"19","author":"Krupp","year":"2013","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2026.107026_bib0019","doi-asserted-by":"crossref","first-page":"E1778","DOI":"10.1212\/WNL.0000000000006471","article-title":"Use of newer disease-modifying therapies in pediatric multiple sclerosis in the US","volume":"91","author":"Krysko","year":"2018","journal-title":"Neurology."},{"key":"10.1016\/j.msard.2026.107026_bib0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/ana.25737","article-title":"Real-world effectiveness of initial disease-modifying therapies in pediatric multiple sclerosis","volume":"88","author":"Krysko","year":"2020","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0021","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jamaneurol.2018.1814","article-title":"Association of MOG-IgG serostatus with relapse after acute disseminated encephalomyelitis and proposed diagnostic criteria for MOG-IgG-associated disorders","volume":"75","author":"L\u00f3pez-Chiriboga","year":"2018","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0022","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","article-title":"Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis","volume":"4","author":"Miller","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0023","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000200275","article-title":"MOG CNS autoimmunity and MOGAD","volume":"11","author":"Moseley","year":"2024","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107026_bib0025","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.spen.2017.08.007","article-title":"The spectrum of inflammatory acquired demyelinating syndromes in children","volume":"24","author":"Neuteboom","year":"2017","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0026","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200065","article-title":"Early immunotherapy and longer corticosteroid treatment are associated with lower risk of relapsing disease course in pediatric MOGAD","volume":"10","author":"Nosadini","year":"2023","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107026_bib0027","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/NXI.0000000000000322","article-title":"MOG antibody-positive, benign, unilateral, cerebral cortical encephalitis with epilepsy","volume":"4","author":"Ogawa","year":"2017","journal-title":"Neurol. Neuroimmunol. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107026_bib0028","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S1474-4422(22)00200-9","article-title":"Diagnosis and classification of optic neuritis","volume":"21","author":"Petzold","year":"2022","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0029","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1055\/a-2308-3788","article-title":"Clinico-radiologic spectrum and outcome of pediatric acquired demyelinating disorders of Central Nervous system: a retrospective Indian Tertiary Care Hospital cohort","volume":"55","author":"Prithviraj","year":"2024","journal-title":"Neuropediatrics."},{"key":"10.1016\/j.msard.2026.107026_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102718","article-title":"Anti-MOG associated disorder-clinical and radiological characteristics compared to AQP4-IgG+ NMOSD-A single-center experience","volume":"48","author":"Rempe","year":"2021","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107026_bib0031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00415-025-13245-3","article-title":"MOGAD-related epilepsy: a systematic characterization of age-dependent clinical, fluid, imaging and neurophysiological features","volume":"272","author":"Rubin","year":"2025","journal-title":"J. Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0032","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2023.105075","article-title":"Characteristics and predictors of disease course in children initially presenting with ADEM","volume":"80","author":"Rutatangwa","year":"2023","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107026_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102057","article-title":"Seizure occurrence in myelin oligodendrocyte glycoprotein antibody-associated disease: a systematic review and meta-analysis","volume":"42","author":"Shen","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107026_bib0034","first-page":"1","article-title":"MRI characteristics during attack and remission distinguish patients with MOG antibody-associated disease from multiple sclerosis","author":"Syc-Mazurek","year":"2025","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107026_bib0036","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1080\/00207454.2020.1720676","article-title":"Unilateral cerebral cortical encephalitis with epilepsy: a possible special phenotype of MOG antibody-associated disorders","volume":"130","author":"Tao","year":"2020","journal-title":"Int. J. Neurosci."},{"key":"10.1016\/j.msard.2026.107026_bib0037","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","article-title":"Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria","volume":"17","author":"Thompson","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0038","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1136\/jnnp-2024-333463","article-title":"Oral corticosteroid dosage and taper duration at onset in myelin oligodendrocyte glycoprotein antibody-associated disease influences time to first relapse","volume":"95","author":"Trewin","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107026_bib0039","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/jnnp-2024-333464","article-title":"Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease","volume":"96","author":"Virupakshaiah","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.msard.2026.107026_bib0040","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1474-4422(14)70093-6","article-title":"Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research","volume":"13","author":"Waldman","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0041","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejpn.2024.07.002","article-title":"Long term outcome in non-multiple sclerosis paediatric acquired demyelinating syndromes","volume":"52","author":"Wassmer","year":"2024","journal-title":"Eur. J. Paediatr. Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0042","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1212\/WNL.0000000000002880","article-title":"International Pediatric MS Study Group Global Members Symposium report","volume":"87","author":"Wassmer","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107026_bib0043","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1001\/jamaneurol.2019.2940","article-title":"Serial anti-myelin oligodendrocyte glycoprotein antibody analyses and outcomes in children with demyelinating syndromes","volume":"77","author":"Waters","year":"2020","journal-title":"JAMa Neurol."},{"key":"10.1016\/j.msard.2026.107026_bib0044","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2024.105435","article-title":"Consensus recommendations for diagnosis and treatment of Multiple sclerosis: 2023 revision of the MENACTRIMS guidelines","volume":"83","author":"Yamout","year":"2024","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107026_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2020.102260","article-title":"Epidemiology of pediatric multiple sclerosis: a systematic literature review and meta-analysis","volume":"44","author":"Yan","year":"2020","journal-title":"Mult. Scler. Relat. Disord."},{"key":"10.1016\/j.msard.2026.107026_bib0046","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.0000000000210886","article-title":"Frequency of the supporting features for MOGAD diagnosis in patients with multiple sclerosis (P11-8.019)","volume":"104","author":"Zara","year":"2025","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2026.107026_bib0035","doi-asserted-by":"crossref","unstructured":"Wingerchuk, D.M., Banwell, B., Bennett, J.L., Cabre, P., Carroll, W., Chitnis, T., de Seze, J., Fujihara, K., Greenberg, B., Jacob, A., Jarius, S., Lana-Peixoto, M., Levy, M., Simon, J.H., Tenembaum, S., Traboulsee, A.L., Waters, P., Wellik, K.E., Weinshenker, B.G.; International panel for NMO diagnosis. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015 Jul 14;85(2):177-89. doi: 10.1212\/WNL.0000000000001729.","DOI":"10.1212\/WNL.0000000000001729"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000623?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000623?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:05:53Z","timestamp":1785755153000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826000623"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":46,"alternative-id":["S2211034826000623"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107026","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First demyelinating attack in children: A twelve year single center cohort","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107026"}}